P30 Pharmacist led allergy clinic: Improving paediatric patient care

Conclusions The introduction of a paediatric pharmacist clinic was received positively by the paediatric allergy MDT and the paediatric allergy patients seen (excellent results from patient satisfaction survey). It has contributed to improving patient care, by improving patient safety and reducing waiting times. The outpatient clinic waiting time was reduced by 64% for eczema review after the initiation of topical immunomodulatory therapy for those patients that were referred to the pharmacist clinic and 100% of medication reviews were carried out within 4 weeks of referral. The clinics had significant cost saving implications through deprescribing and consultant clinic time. Due to the significant success of this project, pharmacist led allergy clinics have been implemented on weekly basis and the pharmacist manages own patient case load. References England.nhs.uk. 2013. Available from: https://www.england.nhs.uk/wp-content/uploads/2013/06/e03- paedi-medi-allergy.pdf Bsaci.org. 2019. Available from: https://www.bsaci.org/about/BSACI_Paed_allergy_standards_2-13.pdf Standards for paediatric allergy services in secondary care. BSACI Overview | Atopic eczema in under 12s: diagnosis and management | Guidance | NICE [Internet]. Nice.org.uk. 2019. Available from: https://www.nice.org.uk/guidance/cg57
Source: Archives of Disease in Childhood - Category: Pediatrics Authors: Tags: Abstract from the Neonatal and Paediatric Pharmacists Conference 2022 Source Type: research